CNY 12.66
(0.88%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 14.05 Billion | 13.22 Billion | 12.57 Billion | 8.45 Billion | 7.46 Billion | 8.36 Billion |
Cost of Revenue | 12.59 Billion | 10.86 Billion | 9.77 Billion | 6.38 Billion | 5.26 Billion | 4.62 Billion |
Gross Profit | 1.45 Billion | 2.35 Billion | 2.79 Billion | 2.06 Billion | 2.19 Billion | 3.73 Billion |
Operating Expenses | 960.98 Million | 638.38 Million | 725.99 Million | 652.65 Million | 259.63 Million | 251.67 Million |
Selling, General and Administrative Expenses | 239.62 Million | 265.78 Million | 266.29 Million | 234.37 Million | 192.38 Million | 196.62 Million |
Research and Development Expenses | 793.91 Million | 584.43 Million | 530.21 Million | 405.69 Million | 197 Million | 144.38 Million |
Other Expenses | -72.54 Million | -211.82 Million | -70.51 Million | 12.57 Million | -129.75 Million | 6.94 Million |
Cost and Expenses | 13.55 Billion | 11.5 Billion | 10.5 Billion | 7.03 Billion | 5.52 Billion | 4.87 Billion |
Operating Income | 494.76 Million | 1.73 Billion | 1.75 Billion | 1.55 Billion | 1.59 Billion | 3.24 Billion |
Interest Expense | 338.13 Million | 345.9 Million | 183.46 Million | 107.98 Million | 159.28 Million | 106.88 Million |
Income Tax Expense | 108.04 Million | 169.17 Million | 352.64 Million | 144.35 Million | 292.25 Million | 417.65 Million |
Earnings before Tax | 474.6 Million | 854.23 Million | 1.66 Billion | 1.16 Billion | 1.59 Billion | 3.24 Billion |
Net Income | 366.55 Million | 685.11 Million | 1.31 Billion | 1.01 Billion | 1.29 Billion | 2.83 Billion |
Earnings Per Share Basic | 0.07 | 0.14 | 0.29 | 0.24 | 0.32 | 0.69 |
Earnings Per Share Diluted | 0.07 | 0.14 | 0.29 | 0.24 | 0.32 | 0.69 |
Weighted Average Shares Outstanding | 5.23 Billion | 4.95 Billion | 4.47 Billion | 4.23 Billion | 4.05 Billion | 4.1 Billion |
Weighted Average Shares Outstanding (Diluted) | 5.23 Billion | 4.95 Billion | 4.47 Billion | 4.23 Billion | 4.05 Billion | 4.1 Billion |
Gross Margin | 0.10 | 0.18 | 0.22 | 0.24 | 0.29 | 0.45 |
EBIT Margin | 0.32 | 0.35 | 0.34 | 0.39 | 0.48 | 0.60 |
Profit Margin | 0.03 | 0.05 | 0.10 | 0.12 | 0.17 | 0.34 |
EBITDA | 4.45 Billion | 4.33 Billion | 3.97 Billion | 3.15 Billion | 3.41 Billion | 4.82 Billion |
Earnings Before Tax Margin | 0.04 | 0.13 | 0.14 | 0.18 | 0.21 | 0.39 |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Revenue | 4.13 Billion | 4.08 Billion | 3.55 Billion | 14.05 Billion | 3.89 Billion | 3.68 Billion |
Cost of Revenue | 3.74 Billion | 3.85 Billion | 3.02 Billion | 12.59 Billion | 3.61 Billion | 3.38 Billion |
Gross Profit | 387 Million | 226.8 Million | 528.07 Million | 1.45 Billion | 279.69 Million | 299.05 Million |
Operating Expenses | 520.9 Million | 356.88 Million | 214.42 Million | 371.61 Million | -5.27 Million | 275.67 Million |
Selling, General and Administrative Expenses | 280.61 Million | 195.24 Million | 239.45 Million | - | -404.98 Million | 596.86 Million |
Research and Development Expenses | 175.91 Million | 126.51 Million | 141.95 Million | - | 284.11 Million | 192.99 Million |
Other Expenses | -64.37 Million | -35.12 Million | -9.5 Million | -20.15 Million | -14.64 Million | -941.1 Thousand |
Cost and Expenses | 4.26 Billion | 4.21 Billion | 3.24 Billion | 12.96 Billion | 3.61 Billion | 3.66 Billion |
Operating Income | -133.89 Million | -130.07 Million | 208.27 Million | 494.76 Million | 241.9 Million | 37.82 Million |
Interest Expense | 80.4 Million | 82.06 Million | 76.78 Million | 322.51 Million | 77.24 Million | 80.82 Million |
Income Tax Expense | 27.92 Million | 22.88 Million | 80.02 Million | 108.04 Million | 33.29 Million | 34.23 Million |
Earnings before Tax | 53.36 Million | 104.27 Million | 198.76 Million | 474.6 Million | 227.25 Million | 36.88 Million |
Net Income | 62.87 Million | 65.55 Million | 118.74 Million | 366.55 Million | 193.96 Million | 2.64 Million |
Earnings Per Share Basic | 0.01 | 0.01 | 0.02 | - | 0.04 | 0.00 |
Earnings Per Share Diluted | 0.01 | 0.01 | 0.02 | - | 0.04 | 0.00 |
Weighted Average Shares Outstanding | 4.98 Billion | 4.98 Billion | 5.93 Billion | 5.23 Billion | 4.98 Billion | 4.98 Billion |
Weighted Average Shares Outstanding (Diluted) | 4.98 Billion | 4.98 Billion | 5.93 Billion | 5.23 Billion | 4.98 Billion | 4.98 Billion |
Gross Margin | 0.09 | 0.06 | 0.15 | 0.10 | 0.07 | 0.08 |
EBIT Margin | 0.03 | 0.20 | 0.10 | - | 0.08 | 0.01 |
Profit Margin | 0.02 | 0.02 | 0.03 | 0.03 | 0.05 | 0.00 |
EBITDA | 133.77 Million | 819.71 Million | 359.17 Million | - | 297.92 Million | 36.13 Million |
Earnings Before Tax Margin | -0.03 | -0.03 | 0.06 | 0.04 | 0.06 | 0.01 |
8960
ORCHPHARMA
SKHCF
NIKL
008930
ZOREN